Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

12.97
Delayed Data
As of Sep 27
 +0.03 / +0.23%
Today’s Change
9.59
Today|||52-Week Range
22.11
-24.99%
Year-to-Date
No recent news for Sucampo Pharmaceuticals Inc.

Today’s Trading

Previous close12.94
Today’s open12.89
Day’s range12.62 - 13.06
Volume287,924
Average volume (3 months)376,551
Market cap$592.9M
Dividend yield--
Data as of 09/27/2016

Growth & Valuation

Earnings growth (last year)+151.72%
Earnings growth (this year)+8.15%
Earnings growth (next 5 years)+55.50%
Revenue growth (last year)+32.68%
P/E ratio48.0
Price/Sales5.16
Price/Book6.81

Competitors

 Today’s
change
Today’s
% change
VTAEVitae Pharmaceutical...+0.06+0.29%
CLCDCoLucid Pharmaceutic...+0.40+1.23%
ARDXArdelyx Inc+0.75+6.11%
CTMXCytomX Therapeutics ...+0.09+0.57%
Data as of 09/27/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$153.2M
Annual profit (last year)$33.4M
Net profit margin21.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Peter S. Greenleaf
Chief Financial Officer
Andrew P. Smith
Corporate headquarters
Rockville, Maryland

Forecasts

Search for Jobs